OTLC 净利润历史(2017–2026)
Oncotelic Therapeutics, Inc. (OTLC) 年度净利润历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
$249.3MFY2026 · FY2017 以来:-$13.7M → $249.3M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2026 | $249.3M | +5610.7% |
| FY2025 | -$4.5M | +42.8% |
| FY2024 | -$7.9M | -255.1% |
| FY2023 | $5.1M | +154.3% |
| FY2022 | -$9.4M | +1.2% |
| FY2021 | -$9.5M | -43.2% |
| FY2020 | -$6.6M | -831.3% |
| FY2019 | -$712,738 | +94.8% |
| FY2018 | -$13.8M | -1.2% |
| FY2017 | -$13.7M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议